Pharmacogenetics of carbamazepine
Carbamazepine (CMZ) is a drug from the group of anticonvulsants, similar in chemical structure to tricyclic antidepressants. CMZ is widely used for mental disorders and neurological diseases. The lecture discusses the safety of CMZ in respect to personalized medicine, while considering the pharmacog...
Saved in:
Main Authors: | N. A. Shnayder, E. N. Bochanova, D. V. Dmitrenko, R. F. Nasyrova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-01-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/503 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
by: R. F. Nasyrova, et al.
Published: (2018-01-01) -
Genetic Risk Factors for Adverse Drug Reactions
by: D. A. Sychev, et al.
Published: (2022-04-01) -
EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS
by: E. A. Sоkоvа, et al.
Published: (2018-06-01) -
Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01) -
Genetic features of a patient may influence the efficacy and safety profile of a medicinal product
by: D. A. Sychev
Published: (2024-07-01)